Pacer Advisors, Inc. Invitae Corp Transaction History

Pacer Advisors, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 05, 2022	SELL	$6.28 - $15.59 $24,969 - $61,985	-3,976 Closed	0 $0
Q4 2021 Feb 03, 2022	BUY	$14.7 - $28.67 $58,447 - $113,991	3,976 New	3,976 $61,000
Q3 2021 Oct 15, 2021	SELL	$24.31 - $33.6 $89,582 - $123,816	-3,685 Closed	0 $0
Q2 2021 Jul 21, 2021	BUY	$26.09 - $40.4 $48,449 - $75,022	1,857 Added 101.59%	3,685 $124,000
Q1 2021 Apr 05, 2021	SELL	$33.06 - $56.93 $16,596 - $28,578	-502 Reduced 21.55%	1,828 $70,000
Q4 2020 Jan 20, 2021	SELL	$39.09 - $57.4 $163,005 - $239,358	-4,170 Reduced 64.15%	2,330 $97,000
Q3 2020 Oct 19, 2020	BUY	$28.43 - $44.67 $184,795 - $290,355	6,500 New	6,500 $282,000
Q4 2018 Feb 13, 2019	SELL	$9.26 - $16.38 $39,429 - $69,746	-4,258 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$7.54 - $18.31 $32,105 - $77,963	4,258 New	4,258 $71,000

1.92M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.